2 Biotechs Began Trading Thursday. One Jumped, the Other Plunged.

Barrons2021-12-17

The IPO market is set to close out 2021 with a thud after Immix Biopharma, a biotech, dropped nearly 27% below its offer price. Immix (ticker: IMMX) is the third company this week to trade below its ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Junchan
2021-12-17
Junchan
Ok
- Junchan:
  Ok
- Junchan:
  Ok
- Junchan:
  Ok
- Junchan:
  Ok
- Junchan:
  Ok
ppyy
2021-12-17
ppyy
Ok
- Ddsl:
  Ok
- ppyy:
  ok
HLPA
2021-12-17
HLPA
Both will plunge deeper
- jaswsf:
  Ok
LMC90
2021-12-17
LMC90
Like please
Gee1
2021-12-17
Gee1
good
javiery
2021-12-17
javiery
Like
- LMC90:
  👍
- Alexlee81:
  thanks
- LEEQF:
  Commented

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1131183374?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-12-17 15:00","share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","id":"1131183374","market":"us","top_or_hot":-1,"title":"2 Biotechs Began Trading Thursday. One Jumped, the Other Plunged.","media":"Barrons","content":"<div>\n<p>The IPO market is set to close out 2021 with a thud after Immix Biopharma, a biotech, dropped nearly 27% below its offer price.\nImmix (ticker: IMMX) is the third company this week to trade below its ...</p>\n\n<a href=\"https://www.marketwatch.com/articles/two-biotech-ipos-set-to-start-trading-on-thursday-51639676485?mod=newsviewer_click_seemore\">Source Link</a>\n\n</div>\n","source":"market_watch","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Biotechs Began Trading Thursday. One Jumped, the Other Plunged.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Biotechs Began Trading Thursday. One Jumped, the Other Plunged.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-17 15:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/articles/two-biotech-ipos-set-to-start-trading-on-thursday-51639676485?mod=newsviewer_click_seemore><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The IPO market is set to close out 2021 with a thud after Immix Biopharma, a biotech, dropped nearly 27% below its offer price.\nImmix (ticker: IMMX) is the third company this week to trade below its ...</p>\n\n<a href=\"https://www.marketwatch.com/articles/two-biotech-ipos-set-to-start-trading-on-thursday-51639676485?mod=newsviewer_click_seemore\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IMMX","symbol_name":"Immix Biopharma, Inc","start_time":0,"source_url":"https://www.marketwatch.com/articles/two-biotech-ipos-set-to-start-trading-on-thursday-51639676485?mod=newsviewer_click_seemore","article_id":"1131183374","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1131183374","pubTimestamp":1639724439,"columns":[],"sourceInfo":{"source_id":"market_watch","name":"华尔街大事件"},"weMediaInfo":null,"summary":"The IPO market is set to close out 2021 with a thud after Immix Biopharma, a biotech, dropped nearly","collect":0,"end_time":0,"defaultTopTitle":"marketwatch.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"IMMX":"Immix Biopharma, Inc","BNOX":"Bionomics Limited"},"translate_title":"两家生物技术公司周四开始交易。一个跳，另一个跳。","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BNOX":0.9,"IMMX":0.9},"content_text":"The IPO market is set to close out 2021 with a thud after Immix Biopharma, a biotech, dropped nearly 27% below its offer price.\nImmix (ticker: IMMX) is the third company this week to trade below its initial public offering price. On Wednesday, Genenta Science (GNTA), a biotech, fell more than 4%, while Fresh Vine Wine (VINE), a producer of low-carb wine, plunged nearly 30% the day before.\nBionomics (BNOX) also opened on Thursday, with shares rising more than 19%. The biotech is not considered an IPO since its stock already trades on the Australian Securities Exchange.\nIPOs have slowed considerably in December. Ten companies have gone public this month in traditional IPOs, raising $4.9 billion, Dealogic said. This compares to last year, when 21 companies listed their shares using traditional offerings, collecting $12.8 billion.\nThe IPO market is expected to go on break next week for the holidays, with many deals going on hold. New issues are expected to reopen in mid-January. No companies are expected to go public on Friday using a traditional offering.\nSix companies, including Immix and Bionomics, have priced their deals this week. Sidus Space (SIDU), a satellite company, turned in a strong performance when its stock rocketed nearly 144% Tuesday. On Wednesday, the stock of Samsara (IOT), an internet of things company, rose more than 7%.\nShares of Immix opened at $5 and dropped. The stock closed at $3.67, down $1.33 from its offer price.\nImmix is developing tissue-specific therapeutics to treat cancer and inflammation. Its lead product candidate, IMX-110, is currently in Phase 1b/2a clinical trials for solid tumors in the United States and Australia, a prospectus said.\nImmix increased the size of its deal to $4.2 million shares, which it sold at $5 each. The Los Angeles company had planned on selling roughly 3.83 million shares at $5 to $6 each.\nShares of Bionomcis, meanwhile, opened at $22 and ended at $14.73, up $2.38 cents from its offer price.\nBionomics is developing therapies for persons suffering from serious central nervous system disorders. Its lead product candidate, BNC210, treats social anxiety disorder and post-traumatic stress disorder, according to a prospectus.\nBionomics sold 1.62 million American Depositary Shares, or ADSs, at $12.35 a share. Each ADS represents 180 ordinary shares of Bionomics.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9000983862,"gmtCreate":1639727296662,"gmtModify":1676533493217,"author":{"id":"3582060962041245","authorId":"3582060962041245","name":"Junchan","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3582060962041245","authorIdStr":"3582060962041245"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":251,"repostSize":0,"link":"https://ttm.financial/post/9000983862","repostId":1131183374,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":103097210,"gmtCreate":1658896624717,"gmtModify":1675837926001,"authorId":3582060962041245,"author":{"id":3582060962041245,"idStr":"3582060962041245","authorId":3582060962041245,"name":"Junchan","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9000983862,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">Ok</span>","text":"<span class=\"s1\">Ok</span>","html":"<span class=\"s1\">Ok</span>"},{"id":103059320,"gmtCreate":1658720765376,"gmtModify":1675837367771,"authorId":3582060962041245,"author":{"id":3582060962041245,"idStr":"3582060962041245","authorId":3582060962041245,"name":"Junchan","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9000983862,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"},{"id":103050868,"gmtCreate":1658673364186,"gmtModify":1675837240012,"authorId":3582060962041245,"author":{"id":3582060962041245,"idStr":"3582060962041245","authorId":3582060962041245,"name":"Junchan","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9000983862,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"},{"id":103032548,"gmtCreate":1658549156963,"gmtModify":1675836970330,"authorId":3582060962041245,"author":{"id":3582060962041245,"idStr":"3582060962041245","authorId":3582060962041245,"name":"Junchan","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9000983862,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"},{"id":104397390,"gmtCreate":1666090177665,"gmtModify":1666090181051,"authorId":3582060962041245,"author":{"id":3582060962041245,"idStr":"3582060962041245","authorId":3582060962041245,"name":"Junchan","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9000983862,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">Ok</span>","text":"<span class=\"s1\">Ok</span>","html":"<span class=\"s1\">Ok</span>"}],"langContent":"EN"},{"id":699053757,"gmtCreate":1639726907459,"gmtModify":1676532347419,"author":{"id":"3553039767902975","authorId":"3553039767902975","name":"ppyy","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3553039767902975","authorIdStr":"3553039767902975"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/699053757","repostId":1131183374,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7021087,"gmtCreate":1639727947669,"gmtModify":1663238794152,"authorId":3572567683672897,"author":{"id":3572567683672897,"idStr":"3572567683672897","authorId":3572567683672897,"name":"Ddsl","avatar":"https://static.tigerbbs.com/4349a7a2362135d26685a45e48253c3d","vip":1,"crmLevel":9,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":699053757,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"},{"id":7020945,"gmtCreate":1639726912651,"gmtModify":1663238794058,"authorId":3553039767902975,"author":{"id":3553039767902975,"idStr":"3553039767902975","authorId":3553039767902975,"name":"ppyy","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":699053757,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"CN"},{"id":699053003,"gmtCreate":1639726733824,"gmtModify":1676532347404,"author":{"id":"3569274903458035","authorId":"3569274903458035","name":"HLPA","avatar":"https://static.tigerbbs.com/07e7b987a9127c5a47dbc3ae02db548b","vip":1,"hat":"https://static.tigerbbs.com/646756f1284a5a6480ed02cc4fa7d1d2","crmLevel":8,"crmLevelSwitch":1,"idStr":"3569274903458035","authorIdStr":"3569274903458035"},"htmlText":"Both will plunge deeper","listText":"Both will plunge deeper","text":"Both will plunge deeper","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/699053003","repostId":1131183374,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7020948,"gmtCreate":1639726965033,"gmtModify":1663238794433,"authorId":3571893886885807,"author":{"id":3571893886885807,"idStr":"3571893886885807","authorId":3571893886885807,"name":"jaswsf","avatar":"https://static.tigerbbs.com/ed600b3aaba5cb409e893412ae0ee2a9","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":699053003,"type":1,"supId":0,"prevId":0,"content":"<u>Ok</u>","text":"<u>Ok</u>","html":"<u>Ok</u>"}],"langContent":"CN"},{"id":9000989479,"gmtCreate":1639726550129,"gmtModify":1676533493209,"author":{"id":"3577534747443372","authorId":"3577534747443372","name":"LMC90","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3577534747443372","authorIdStr":"3577534747443372"},"htmlText":"Like please","listText":"Like please","text":"Like please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9000989479","repostId":1131183374,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9000989113,"gmtCreate":1639726294397,"gmtModify":1676533493202,"author":{"id":"3555136548043615","authorId":"3555136548043615","name":"Gee1","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"hat":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":5,"crmLevelSwitch":0,"idStr":"3555136548043615","authorIdStr":"3555136548043615"},"htmlText":"good","listText":"good","text":"good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9000989113","repostId":1131183374,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":699024411,"gmtCreate":1639726282828,"gmtModify":1676532347318,"author":{"id":"3578269878229068","authorId":"3578269878229068","name":"javiery","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3578269878229068","authorIdStr":"3578269878229068"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/699024411","repostId":1131183374,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":100003670,"gmtCreate":1639726558802,"gmtModify":1663241392260,"authorId":3577534747443372,"author":{"id":3577534747443372,"idStr":"3577534747443372","authorId":3577534747443372,"name":"LMC90","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":699024411,"type":1,"supId":0,"prevId":0,"content":"👍","text":"👍","html":"👍"},{"id":7022111,"gmtCreate":1639736115449,"gmtModify":1663238799748,"authorId":4098656676523110,"author":{"id":4098656676523110,"idStr":"4098656676523110","authorId":4098656676523110,"name":"Alexlee81","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":699024411,"type":1,"supId":7020911,"prevId":0,"content":"<u>thanks</u>","text":"<u>thanks</u>","html":"<u>thanks</u>"},{"id":7020911,"gmtCreate":1639726360695,"gmtModify":1663238795148,"authorId":3572235673675008,"author":{"id":3572235673675008,"idStr":"3572235673675008","authorId":3572235673675008,"name":"LEEQF","avatar":"https://static.tigerbbs.com/ead66a2c538631d15658309f808c7d40","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":699024411,"type":1,"supId":0,"prevId":0,"content":"Commented","text":"Commented","html":"Commented"}],"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":44,"commentSize":20,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1131183374"}